T1	Participants 197 271	patients who are already on an aspirin regimen and among those who are not
T2	Participants 341 505	10,010 patients who were preparing to undergo noncardiac surgery and were at risk for vascular complications to receive aspirin or placebo and clonidine or placebo.
